1. Home
  2. AGCO vs HALO Comparison

AGCO vs HALO Comparison

Compare AGCO & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGCO
  • HALO
  • Stock Information
  • Founded
  • AGCO 1990
  • HALO 1998
  • Country
  • AGCO United States
  • HALO United States
  • Employees
  • AGCO N/A
  • HALO N/A
  • Industry
  • AGCO Industrial Machinery/Components
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AGCO Industrials
  • HALO Health Care
  • Exchange
  • AGCO Nasdaq
  • HALO Nasdaq
  • Market Cap
  • AGCO 7.5B
  • HALO 9.0B
  • IPO Year
  • AGCO 1992
  • HALO N/A
  • Fundamental
  • Price
  • AGCO $110.72
  • HALO $65.56
  • Analyst Decision
  • AGCO Buy
  • HALO Buy
  • Analyst Count
  • AGCO 9
  • HALO 10
  • Target Price
  • AGCO $112.67
  • HALO $73.40
  • AVG Volume (30 Days)
  • AGCO 765.9K
  • HALO 2.2M
  • Earning Date
  • AGCO 11-04-2025
  • HALO 10-30-2025
  • Dividend Yield
  • AGCO 3.31%
  • HALO N/A
  • EPS Growth
  • AGCO N/A
  • HALO 68.93
  • EPS
  • AGCO 1.34
  • HALO 4.37
  • Revenue
  • AGCO $10,172,100,000.00
  • HALO $1,178,672,000.00
  • Revenue This Year
  • AGCO N/A
  • HALO $32.57
  • Revenue Next Year
  • AGCO $5.03
  • HALO $23.25
  • P/E Ratio
  • AGCO $82.84
  • HALO $15.12
  • Revenue Growth
  • AGCO N/A
  • HALO 34.97
  • 52 Week Low
  • AGCO $73.79
  • HALO $42.01
  • 52 Week High
  • AGCO $121.16
  • HALO $79.50
  • Technical
  • Relative Strength Index (RSI)
  • AGCO 52.95
  • HALO 31.20
  • Support Level
  • AGCO $104.36
  • HALO $73.06
  • Resistance Level
  • AGCO $110.93
  • HALO $76.30
  • Average True Range (ATR)
  • AGCO 2.84
  • HALO 2.33
  • MACD
  • AGCO 0.17
  • HALO -1.57
  • Stochastic Oscillator
  • AGCO 85.86
  • HALO 3.81

About AGCO AGCO Corporation

Agco is a global manufacturer of agricultural equipment. Its main machine brands are Fendt, Massey Ferguson, and Valtra; its initiatives in precision agriculture have been organized under the PTx umbrella following a series of acquisitions. While a global business, Agco's sales skew heavily toward Europe/Middle East, representing 50%-60% of sales and even more of operating profits. The company is trying to increase its exposure to the larger North and South American markets. Its products are available through a global dealer network, which includes over 3,000 dealer and distribution locations and reach into over 140 countries. Additionally, Agco offers retail and wholesale financing to customers through its unconsolidated joint venture with Rabobank of the Netherlands.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: